Sanofi Deepens Investment in mRNA Vaccines with Translate Bio Collaboration

By Heather Cartwright

Pharma Deals Review: Vol 2018 Issue 6 (Table of Contents)

Published: 26 Jun-2018

DOI: 10.3833/pdr.v2018.i6.2329     ISSN: 1756-7874

Section: Research & Development



Less than 2 weeks after filing for an IPO, Translate Bio has secured a high-profile R&D partnership with Sanofi Pasteur, the vaccines unit of Sanofi, to develop next-generation mRNA vaccines for up to five undisclosed infectious disease pathogens...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details